Your browser doesn't support javascript.
loading
Long-Term Toxicity of 213Bi-Labelled BSA in Mice.
Dorso, Laëtitia; Bigot-Corbel, Edith; Abadie, Jérôme; Diab, Maya; Gouard, Sébastien; Bruchertseifer, Frank; Morgenstern, Alfred; Maurel, Catherine; Chérel, Michel; Davodeau, François.
Afiliação
  • Dorso L; Nuclear Oncology, Nantes-Angers Cancer Research Center (CRCNA) UMR 892 Inserm, Nantes, France.
  • Bigot-Corbel E; University of Nantes, Nantes, France.
  • Abadie J; CNRS, UMR 6299, Nantes, France.
  • Diab M; L'UNAM University, Oniris, AMaROC Unit, Nantes, France.
  • Gouard S; Nuclear Oncology, Nantes-Angers Cancer Research Center (CRCNA) UMR 892 Inserm, Nantes, France.
  • Bruchertseifer F; University of Nantes, Nantes, France.
  • Morgenstern A; CNRS, UMR 6299, Nantes, France.
  • Maurel C; Biochemistry Department, Laënnec Hospital, Nantes, France.
  • Chérel M; L'UNAM University, Oniris, AMaROC Unit, Nantes, France.
  • Davodeau F; Nuclear Oncology, Nantes-Angers Cancer Research Center (CRCNA) UMR 892 Inserm, Nantes, France.
PLoS One ; 11(3): e0151330, 2016.
Article em En | MEDLINE | ID: mdl-26982495
BACKGROUND: Short-term toxicological evaluations of alpha-radioimmunotherapy have been reported in preclinical assays, particularly using bismuth-213 (213Bi). Toxicity is greatly influenced not only by the pharmacokinetics and binding specificity of the vector but also by non-specific irradiation due to the circulating radiopharmaceutical in the blood. To assess this, an acute and chronic toxicity study was carried out in mice injected with 213Bi-labelled Bovine Serum Albumin (213Bi-BSA) as an example of a long-term circulating vector. METHOD: Biodistribution of 213Bi-BSA and 125I-BSA were compared in order to evaluate 213Bi uptake by healthy organs. The doses to organs for injected 213Bi-BSA were calculated. Groups of nude mice were injected with 3.7, 7.4 and 11.1 MBq of 213Bi-BSA and monitored for 385 days. Plasma parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN) and creatinine, were measured and blood cell counts (white blood cells, platelets and red blood cells) were performed. Mouse organs were examined histologically at different time points. RESULTS: Haematological toxicity was transient and non-limiting for all evaluated injected activities. At the highest injected activity (11.1 MBq), mice died from liver and kidney failure (median survival of 189 days). This liver toxicity was identified by an increase in both ALT and AST and by histological examination. Mice injected with 7.4 MBq of 213Bi-BSA (median survival of 324 days) had an increase in plasma BUN and creatinine due to impaired kidney function, confirmed by histological examination. Injection of 3.7 MBq of 213Bi-BSA was safe, with no plasma enzyme modifications or histological abnormalities. CONCLUSION: Haematological toxicity was not limiting in this study. Liver failure was observed at the highest injected activity (11.1 MBq), consistent with liver damage observed in human clinical trials. Intermediate injected activity (7.4 MBq) should be used with caution because of the risk of long-term toxicity to kidneys.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bismuto / Soroalbumina Bovina Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bismuto / Soroalbumina Bovina Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article